Laurence A. Turka

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jennifer Kamocsay, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Laurence A. Turka

Form 4 holding Chief Scientific Officer

Rubius Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
25,875
Estimated value
Report date
31 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Scientific Officer

Rubius Therapeutics, Inc.

Security class
Common Stock
Shares / value
18,391
Estimated value
Report date
31 Jan 2023
Price
Ownership
Direct

Insider Reports Filed by Laurence A. Turka

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .